Milan Scheidegger holds an M.D. degree from the University of Zurich and completed his Ph.D. in functional and molecular neuroimaging at the Institute for Biomedical Engineering (ETH Zurich). As a resident physician at the Heffter Research Center Zurich (Department of Psychiatry, Psychotherapy, and Psychosomatics) he is currently researching the neurobiology and pharmacology of altered states of consciousness. Together with Dr. Davor Kosanic he co-founded the non-profit social enterprise RECONNECT - Deep Cognitive Tools for Transformational Health Care. As junior group leader he investigates the potential of psychedelics such as ketamine, psilocybin, ayahuasca and DMT to facilitate therapeutic transformation.

On his ethnobotanical expeditions to Mexico, Colombia and Brazil he explored the traditional use of psychoactive plants in indigenous rituals. Together with Prof. Franz Vollenweider and Zen teacher Vanja Palmers, he recently conducted a psilocybin neuroimaging study with long-term meditators in a meditation retreat setting to explore the potential of psilocybin to facilitate transformational experiences, psychospiritual well-being and a deeper understanding of the neurobiology of expanded states of self.

In addition to empirical research, he earned an M.A. (HPK) degree in History and Philosophy of Knowledge (ETH Zurich). His main interests include biosemiotics, philosophy of mind, epistemology and phenomenology of consciousness, mindfulness and deep ecology.

He is current member of the Swiss Society for Psycholytic Therapy (SÄPT) and former scholar of the Swiss Study Foundation and received the Young Investigators Award from the Swiss Society of Biological Psychiatry (2013).